Onderzoeker
Bert Vander Cruyssen
- Disciplines:Palliatieve zorg en zorg rond het levenseinde, Laboratoriumgeneeskunde, Andere translationele wetenschappen, Regeneratieve geneeskunde, Verpleegkunde, Andere klinische wetenschappen, Andere basiswetenschappen, Andere paramedische wetenschappen, Andere gezondheidswetenschappen, Andere medische en gezondheidswetenschappen
Affiliaties
- Vakgroep Inwendige ziekten (Departement)
Lid
Vanaf1 okt 2002 → 30 sep 2018
Publicaties
1 - 10 van 36
- Etanercept in patients with inflammatory hand osteoarthritis (EHOA) : a multicentre, randomised, double-blind, placebo-controlled trial(2018)
Auteurs: Margreet Kloppenburg, Roberta Ramonda, Klaus Bobacz, Wing-Yee Kwok, Tom WJ Huizinga, Feline PB Kroon, Leonardo Punzi, Josef S Smolen, Bert Vander Cruyssen, Ron Wolterbeek, et al.
Pagina's: 1757 - 1764 - Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis(2012)
Auteurs: O Dewit, G D'Haens, F Baert, F Fontaine, S Vermeire, D Franchimont, T Moreels, D Staessen, L Terriere, Bert Vander Cruyssen, et al.
Pagina's: 557 - 562 - Predicting the outcome of ankylosing spondylitis therapy(2011)
Auteurs: Désirée van der Heijde, Robert D Inman, Yanxin Wang, Atul Deodhar, Benjamin Hsu, Mahboob U Rahman, Ben Dijkmans, Piet Geusens, Bert Vander Cruyssen, Eduardo Collantes, et al.
Pagina's: 973 - 981 - Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery(2010)
Auteurs: Bert Vander Cruyssen, Elisa Muñoz-Gomariz, Pilar Font, Juan Mulero, Kurt de Vlam, Annelies Boonen, Janitzia Vazquez-Mellado, Diana Flores, Nathan Vastesaeger, Eduardo Collantes
Pagina's: 73 - 81 - Reduced levels of the TGFB family member GDF15 in spondyloarthritis versus other rheumatic diseases(2010)Volume: 28
Auteurs: Stijn Lambrecht, Filip Van den Bosch, Bert Vander Cruyssen, Filip De Keyser, August Verbruggen, Dieter Deforce, Dirk Elewaut
Pagina's: 626 - 627 - Health status and impact of pain : a comparative study between female patients with the Ehlers-Danlos syndrome, fibromyalgia and rheumatoid arthritis(2010)Volume: 18
Auteurs: Lies Rombaut, Fransiska Malfait, STEVEN RIMBAUT, Bert Vander Cruyssen
Pagina's: S224 - S225 - The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies(2010)
Auteurs: Bert Vander Cruyssen, Patrick Durez, Rene Westhovens, Marie-Joelle Kaiser, Ilse Hoffman, Filip De Keyser
- Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease : attrition rate and evolution of disease activity(2010)
Auteurs: Bert Vander Cruyssen, Patrick Durez, Rene Westhovens, Filip De Keyser
- Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome(2009)
Auteurs: Annelies Boonen, Bert Vander Cruyssen, Kurt de Vlam, Serge Steinfeld, Clio Ribbens, Jan Lenaerts, Filip Van den Bosch, Lode Dewulf, Nathan Vastesaeger
Pagina's: 1249 - 1255 - Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis(2009)
Auteurs: Ken Coppieters, W Laroy, Filip De Keyser, Ilse Hoffman, Filip Van den Bosch, Bert Vander Cruyssen, Michael Drennan, P Rottiers, August Verbruggen, Roland Contreras
Pagina's: 1360 - 1365